CA3277845A1 - Complexe et son utilisation - Google Patents

Complexe et son utilisation

Info

Publication number
CA3277845A1
CA3277845A1 CA3277845A CA3277845A CA3277845A1 CA 3277845 A1 CA3277845 A1 CA 3277845A1 CA 3277845 A CA3277845 A CA 3277845A CA 3277845 A CA3277845 A CA 3277845A CA 3277845 A1 CA3277845 A1 CA 3277845A1
Authority
CA
Canada
Prior art keywords
complex
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3277845A
Other languages
English (en)
Inventor
Shaoshuai MAO
Ying ZANG
Xiang Wei
Hao Luo
Original Assignee
Epigenic Therapeutics Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epigenic Therapeutics Pte Ltd filed Critical Epigenic Therapeutics Pte Ltd
Publication of CA3277845A1 publication Critical patent/CA3277845A1/fr
Pending legal-status Critical Current

Links

CA3277845A 2022-12-23 2023-12-22 Complexe et son utilisation Pending CA3277845A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202211663018.0 2022-12-23
CN202311453875.2 2023-11-02

Publications (1)

Publication Number Publication Date
CA3277845A1 true CA3277845A1 (fr) 2025-11-29

Family

ID=

Similar Documents

Publication Publication Date Title
EP4151652A4 (fr) Anticorps anti-cd73 et son utilisation
EP4197555A4 (fr) Anticorps anti-cd73 et son utilisation
EP4165049A4 (fr) Psychoplastogènes d'isotryptamine et leurs utilisations
EP4234579A4 (fr) Anticorps anti-cd73 et son utilisation
EP4292611A4 (fr) Anticorps anti-cd112r et son utilisation
EP4095157A4 (fr) Anticorps anti-angptl3 et son utilisation
EP4279507A4 (fr) Protéine de liaison à cd73 et son utilisation
EP4339208A4 (fr) Anticorps anti-tigit et leur utilisation
EP4357364A4 (fr) Anticorps et son utilisation
HK40128920A (en) Complex and use thereof
CA3277845A1 (fr) Complexe et son utilisation
CA3292331A1 (en) New micropeptide hmbj and use thereof
EP4090159A4 (fr) Pyrazolylpyrimidines et leur utilisation
HK40112321A (en) SIRPα VARIANT AND USE THEREOF
AU2023901461A0 (en) AIPROPERTY and AIREALESTATE
CA3269972A1 (fr) Composés et leur utilisation
HK40116989A (en) Oxoisoindolinyl-substituted tetrahydropyrimidinedione derivative and use thereof
HK40128877A (en) Cyclopentylpyrazolamine derivative and use thereof
HK40107312A (en) ANTI-βKLOTHO ANTIBODY AND USE THEREOF
AU2023901945A0 (en) Process and use thereof
HK40104148A (zh) 抗il-36r抗体及其用途
HK40108206A (en) Anti-masp-2 antibody and use thereof
AU2022902882A0 (en) Process and use thereof
HK40108849A (en) Nitrophenyl-acrylamides and uses thereof
CA3294208A1 (fr) Anticorps anti-cd200r1 et son utilisation